Publications by authors named "Amy M Fulton"

Claim this Profile
A
An Extract of Taro () Mediates Potent Inhibitory Actions on Metastatic and Cancer Stem Cells by Tumor Cell-Autonomous and Immune-Dependent Mechanisms.
Namita Kundu, Xinrong Ma, Stephen Hoag, Fang Wang, Ahmed Ibrahim, Amy M Fulton

Breast Cancer (Auckl)· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eicosanoids in Cancer: Prostaglandin E Receptor 4 in Cancer Therapeutics and Immunotherapy.
Mc Millan Ching, Jocelyn Reader, Amy M Fulton

Front Pharmacol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple drug resistance-associated protein (MRP4) exports prostaglandin E2 (PGE2) and contributes to metastasis in basal/triple negative breast cancer.
Tyler J Kochel, Jocelyn C Reader, Xinrong Ma, Namita Kundu, Amy M Fulton

Oncotarget· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostaglandin E Receptor EP4 expression, survival and pattern of recurrence in locally advanced NSCLC.
Neha Bhooshan, Paul N Staats, Amy M Fulton, Josephine L Feliciano, Martin J Edelman

Lung Cancer· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upregulation of Cyclooxygenase-2/Prostaglandin E2 (COX-2/PGE2) Pathway Member Multiple Drug Resistance-Associated Protein 4 (MRP4) and Downregulation of Prostaglandin Transporter (PGT) and 15-Prostaglandin Dehydrogenase (15-PGDH) in Triple-Negative Breast Cancer.
Tyler J Kochel, Olga G Goloubeva, Amy M Fulton

Breast Cancer (Auckl)· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A monoclonal antibody against KCNK9 K(+) channel extracellular domain inhibits tumour growth and metastasis.
Han Sun, Liqun Luo, Bachchu Lal, Xinrong Ma, Lieping Chen, Amy M Fulton

Nat Commun· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple drug resistance-associated protein 4 (MRP4), prostaglandin transporter (PGT), and 15-hydroxyprostaglandin dehydrogenase (15-PGDH) as determinants of PGE2 levels in cancer.
Tyler J Kochel, Amy M Fulton

Prostaglandins Other Lipid Mediat· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Divergent roles of CXCR3 isoforms in promoting cancer stem-like cell survival and metastasis.
Yanchun Li, Jocelyn C Reader, Xinrong Ma, Namita Kundu, Tyler Kochel, Amy M Fulton

Breast Cancer Res Treat· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prostaglandin E (PGE) receptor EP4 antagonist protects natural killer cells from PGE-mediated immunosuppression and inhibits breast cancer metastasis.
Xinrong Ma, Dawn Holt, Namita Kundu, Jocelyn Reader, Olga Goloubeva, Amy M Fulton

Oncoimmunology· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulation of host natural killer cell functions in breast cancer via prostaglandin E2 receptors EP2 and EP4.
Dawn M Holt, Xinrong Ma, Namita Kundu, Peter D Collin, Amy M Fulton

J Immunother· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frondoside A inhibits breast cancer metastasis and antagonizes prostaglandin E receptors EP4 and EP2.
Xinrong Ma, Namita Kundu, Peter D Collin, Olga Goloubeva, Amy M Fulton

Breast Cancer Res Treat· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antimetastatic activity isolated from Colocasia esculenta (taro).
Namita Kundu, Patricia Campbell, Brian Hampton, Chen-Yong Lin, Xinrong Ma, Amy M Fulton

Anticancer Drugs· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostaglandin E receptor EP1 suppresses breast cancer metastasis and is linked to survival differences and cancer disparities.
Xinrong Ma, Namita Kundu, Olga B Ioffe, Olga Goloubeva, Raymond Konger, Amy M Fulton

Mol Cancer Res· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antagonism of the prostaglandin E receptor EP4 inhibits metastasis and enhances NK function.
Namita Kundu, Xinrong Ma, Dawn Holt, Olga Goloubeva, Suzanne Ostrand-Rosenberg, Amy M Fulton

Breast Cancer Res Treat· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The chemokine receptors CXCR4 and CXCR3 in cancer.
Amy M Fulton

Curr Oncol Rep· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune-mediated modulation of breast cancer growth and metastasis by the chemokine Mig (CXCL9) in a murine model.
Tonya C Walser, Xinrong Ma, Namita Kundu, Russell Dorsey, Olga Goloubeva, Amy M Fulton

J Immunother· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells.
Pratima Sinha, Virginia K Clements, Amy M Fulton, Suzanne Ostrand-Rosenberg

Cancer Res· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting prostaglandin E EP receptors to inhibit metastasis.
Amy M Fulton, Xinrong Ma, Namita Kundu

Cancer Res· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antagonism of CXCR3 inhibits lung metastasis in a murine model of metastatic breast cancer.
Tonya C Walser, Salah Rifat, Xinrong Ma, Namita Kundu, Chris Ward, Amy M Fulton

Cancer Res· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostaglandin E receptor EP4 antagonism inhibits breast cancer metastasis.
Xinrong Ma, Namita Kundu, Salah Rifat, Tonya Walser, Amy M Fulton

Cancer Res· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclooxygenase inhibitors modulate NK activities that control metastatic disease.
Namita Kundu, Tonya C Walser, Xinrong Ma, Amy M Fulton

Cancer Immunol Immunother· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of chemokines in the biology and therapy of breast cancer.
Tonya C Walser, Amy M Fulton

Breast Dis· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Promoter methylation regulates cyclooxygenase expression in breast cancer.
Xinrong Ma, Qingyuan Yang, Keith T Wilson, Namita Kundu, Stephen J Meltzer, Amy M Fulton

Breast Cancer Res· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclooxygenase inhibitors block cell growth, increase ceramide and inhibit cell cycle.
Namita Kundu, Miriam J Smyth, Leigh Samsel, Amy M Fulton

Breast Cancer Res Treat· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy with interleukin-10 depends on the CXC chemokines inducible protein-10 and monokine induced by IFN-gamma.
Russell Dorsey, Namita Kundu, Qingyuan Yang, Charles S Tannenbaum, Hui Sun, Amy M Fulton

Cancer Res· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis